4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-022309
EXEC. VP AND CLO sold 2,813 shares at $48.58 ($136,656)
- EXEC. VP AND CLO acquired 2,813 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-08-15 | Option exercise 10b5-1 | +2,813 | $25.69 | $72,266 | 106,714 | D |
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-08-15 | Sale 10b5-1 | −2,813 | $48.58 | $136,656 | 103,901 | D |
| Derivatives | |||||||
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-08-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,813 | 24,899 | D | ||
| Open-market sales · 2,813 sh · avg $48.58 · $136,656 | |||||||
Loading xslF345X05/form4-08192025_040801.xml…